1009 related articles for article (PubMed ID: 34764459)
1. Connecting copper and cancer: from transition metal signalling to metalloplasia.
Ge EJ; Bush AI; Casini A; Cobine PA; Cross JR; DeNicola GM; Dou QP; Franz KJ; Gohil VM; Gupta S; Kaler SG; Lutsenko S; Mittal V; Petris MJ; Polishchuk R; Ralle M; Schilsky ML; Tonks NK; Vahdat LT; Van Aelst L; Xi D; Yuan P; Brady DC; Chang CJ
Nat Rev Cancer; 2022 Feb; 22(2):102-113. PubMed ID: 34764459
[TBL] [Abstract][Full Text] [Related]
2. Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma.
Tsang T; Posimo JM; Gudiel AA; Cicchini M; Feldser DM; Brady DC
Nat Cell Biol; 2020 Apr; 22(4):412-424. PubMed ID: 32203415
[TBL] [Abstract][Full Text] [Related]
3. Targeting cuproplasia and cuproptosis in cancer.
Tang D; Kroemer G; Kang R
Nat Rev Clin Oncol; 2024 May; 21(5):370-388. PubMed ID: 38486054
[TBL] [Abstract][Full Text] [Related]
4. Cope with copper: From copper linked mechanisms to copper-based clinical cancer therapies.
Wang X; Zhou M; Liu Y; Si Z
Cancer Lett; 2023 May; 561():216157. PubMed ID: 37011869
[TBL] [Abstract][Full Text] [Related]
5. Metalloallostery and Transition Metal Signaling: Bioinorganic Copper Chemistry Beyond Active Sites.
Pham VN; Chang CJ
Angew Chem Int Ed Engl; 2023 Mar; 62(11):e202213644. PubMed ID: 36653724
[TBL] [Abstract][Full Text] [Related]
6. The copper chaperone CCS facilitates copper binding to MEK1/2 to promote kinase activation.
Grasso M; Bond GJ; Kim YJ; Boyd S; Matson Dzebo M; Valenzuela S; Tsang T; Schibrowsky NA; Alwan KB; Blackburn NJ; Burslem GM; Wittung-Stafshede P; Winkler DD; Marmorstein R; Brady DC
J Biol Chem; 2021 Dec; 297(6):101314. PubMed ID: 34715128
[TBL] [Abstract][Full Text] [Related]
7. Activity-based ratiometric FRET probe reveals oncogene-driven changes in labile copper pools induced by altered glutathione metabolism.
Chung CY; Posimo JM; Lee S; Tsang T; Davis JM; Brady DC; Chang CJ
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18285-18294. PubMed ID: 31451653
[TBL] [Abstract][Full Text] [Related]
8. Copper is required for oncogenic BRAF signalling and tumorigenesis.
Brady DC; Crowe MS; Turski ML; Hobbs GA; Yao X; Chaikuad A; Knapp S; Xiao K; Campbell SL; Thiele DJ; Counter CM
Nature; 2014 May; 509(7501):492-6. PubMed ID: 24717435
[TBL] [Abstract][Full Text] [Related]
9. Copper - a novel stimulator of autophagy.
Zischka H; Kroemer G
Cell Stress; 2020 Apr; 4(5):92-94. PubMed ID: 32420529
[TBL] [Abstract][Full Text] [Related]
10. Copper signaling in the brain and beyond.
Ackerman CM; Chang CJ
J Biol Chem; 2018 Mar; 293(13):4628-4635. PubMed ID: 29084848
[TBL] [Abstract][Full Text] [Related]
11. Recognition- and reactivity-based fluorescent probes for studying transition metal signaling in living systems.
Aron AT; Ramos-Torres KM; Cotruvo JA; Chang CJ
Acc Chem Res; 2015 Aug; 48(8):2434-42. PubMed ID: 26215055
[TBL] [Abstract][Full Text] [Related]
12. Copper metabolism as a unique vulnerability in cancer.
Shanbhag VC; Gudekar N; Jasmer K; Papageorgiou C; Singh K; Petris MJ
Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118893. PubMed ID: 33091507
[TBL] [Abstract][Full Text] [Related]
13. Copper-Dependent Kinases and Their Role in Cancer Inception, Progression and Metastasis.
Vitaliti A; De Luca A; Rossi L
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291728
[TBL] [Abstract][Full Text] [Related]
14. Copper induces hepatic inflammatory responses by activation of MAPKs and NF-κB signalling pathways in the mouse.
Liu H; Guo H; Deng H; Cui H; Fang J; Zuo Z; Deng J; Li Y; Wang X; Zhao L
Ecotoxicol Environ Saf; 2020 Sep; 201():110806. PubMed ID: 32512418
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional profiling reveals ataxia telangiectasia mutated pathways regulate joint copper and arsenic toxicity for hepatic metalloplasia and anti-cancer therapies.
Thirunavukkarasu C; Sharma Y; Tchaikovskaya T; Maslov AY; Gupta S
Life Sci; 2022 Sep; 305():120787. PubMed ID: 35809665
[TBL] [Abstract][Full Text] [Related]
16. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
Foffi G; Pastore A; Piazza F; Temussi PA
Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
[TBL] [Abstract][Full Text] [Related]
17. Copper as a key regulator of cell signalling pathways.
Grubman A; White AR
Expert Rev Mol Med; 2014 May; 16():e11. PubMed ID: 24849048
[TBL] [Abstract][Full Text] [Related]
18. Synthetic fluorescent probes for studying copper in biological systems.
Cotruvo JA; Aron AT; Ramos-Torres KM; Chang CJ
Chem Soc Rev; 2015 Jul; 44(13):4400-14. PubMed ID: 25692243
[TBL] [Abstract][Full Text] [Related]
19. A novel network-based method identifies a cuproplasia-related pan-cancer gene signature to predict patient outcome.
Pham VVH; Jue TR; Bell JL; Luciani F; Michniewicz F; Cirillo G; Vahdat L; Mayoh C; Vittorio O
Hum Genet; 2024 Apr; ():. PubMed ID: 38642129
[TBL] [Abstract][Full Text] [Related]
20. Exploiting cancer vulnerabilities: mTOR, autophagy, and homeostatic imbalance.
Johnson CE; Tee AR
Essays Biochem; 2017 Dec; 61(6):699-710. PubMed ID: 29233879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
